Skip to main content

Main menu

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Editorial Policies
    • Subscribers
    • Advertisers
    • Editorial Board
    • Special Issues
  • Journal Metrics
  • Other Publications
    • In Vivo
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
    • 2008 Nobel Laureates
  • About Us
    • General Policy
    • Contact
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Genomics & Proteomics

User menu

  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Anticancer Research
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Genomics & Proteomics
  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Anticancer Research

Advanced Search

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Editorial Policies
    • Subscribers
    • Advertisers
    • Editorial Board
    • Special Issues
  • Journal Metrics
  • Other Publications
    • In Vivo
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
    • 2008 Nobel Laureates
  • About Us
    • General Policy
    • Contact
  • Visit us on Facebook
  • Follow us on Linkedin
Research ArticleExperimental Studies

AMIGO2 Expression as a Potential Prognostic Biomarker for Gastric Cancer

SHUNSUKE NAKAMURA, MITSURO KANDA, DAI SHIMIZU, CHIE TANAKA, YOSHIKUNI INOKAWA, NORIFUMI HATTORI, MASAMICHI HAYASHI, SUGURU YAMADA, GORO NAKAYAMA, KENJI OMAE, MASAHIKO KOIKE and YASUHIRO KODERA
Anticancer Research December 2020, 40 (12) 6713-6721; DOI: https://doi.org/10.21873/anticanres.14694
SHUNSUKE NAKAMURA
1Department of Gastroenterological Surgery (Surgery II), Nagoya University Graduate School of Medicine, Nagoya, Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
MITSURO KANDA
1Department of Gastroenterological Surgery (Surgery II), Nagoya University Graduate School of Medicine, Nagoya, Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: m-kanda{at}med.nagoya-u.ac.jp
DAI SHIMIZU
1Department of Gastroenterological Surgery (Surgery II), Nagoya University Graduate School of Medicine, Nagoya, Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
CHIE TANAKA
1Department of Gastroenterological Surgery (Surgery II), Nagoya University Graduate School of Medicine, Nagoya, Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
YOSHIKUNI INOKAWA
1Department of Gastroenterological Surgery (Surgery II), Nagoya University Graduate School of Medicine, Nagoya, Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
NORIFUMI HATTORI
1Department of Gastroenterological Surgery (Surgery II), Nagoya University Graduate School of Medicine, Nagoya, Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
MASAMICHI HAYASHI
1Department of Gastroenterological Surgery (Surgery II), Nagoya University Graduate School of Medicine, Nagoya, Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
SUGURU YAMADA
1Department of Gastroenterological Surgery (Surgery II), Nagoya University Graduate School of Medicine, Nagoya, Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
GORO NAKAYAMA
1Department of Gastroenterological Surgery (Surgery II), Nagoya University Graduate School of Medicine, Nagoya, Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
KENJI OMAE
2Department of Innovative Research and Education for Clinicians and Trainees (DiRECT), Fukushima Medical University Hospital, Fukushima, Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
MASAHIKO KOIKE
1Department of Gastroenterological Surgery (Surgery II), Nagoya University Graduate School of Medicine, Nagoya, Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
YASUHIRO KODERA
1Department of Gastroenterological Surgery (Surgery II), Nagoya University Graduate School of Medicine, Nagoya, Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
  • PDF
Loading

Article Information

vol. 40 no. 12 6713-6721
DOI 
https://doi.org/10.21873/anticanres.14694
PMID 
33288564

Published By 
International Institute of Anticancer Research
Print ISSN 
0250-7005
Online ISSN 
1791-7530
History 
  • Received October 13, 2020
  • Revision received October 27, 2020
  • Accepted October 29, 2020
  • Published online December 7, 2020.

Copyright & Usage 
Copyright © 2020 International Institute of Anticancer Research (Dr. George J. Delinasios), All rights reserved.

Author Information

  1. SHUNSUKE NAKAMURA1,
  2. MITSURO KANDA⇑1,
  3. DAI SHIMIZU1,
  4. CHIE TANAKA1,
  5. YOSHIKUNI INOKAWA1,
  6. NORIFUMI HATTORI1,
  7. MASAMICHI HAYASHI1,
  8. SUGURU YAMADA1,
  9. GORO NAKAYAMA1,
  10. KENJI OMAE2,
  11. MASAHIKO KOIKE1 and
  12. YASUHIRO KODERA1
  1. 1Department of Gastroenterological Surgery (Surgery II), Nagoya University Graduate School of Medicine, Nagoya, Japan
  2. 2Department of Innovative Research and Education for Clinicians and Trainees (DiRECT), Fukushima Medical University Hospital, Fukushima, Japan
  1. Correspondence to: Mitsuro Kanda, MD, Ph.D., Department of Gastroenterological Surgery (Surgery II), Nagoya University Graduate School of Medicine, 65 Tsurumai-cho, Showa-ku, Nagoya 466-8550, Japan. Fax: +81 527442255, Tel: +81 527442249, e-mail: m-kanda{at}med.nagoya-u.ac.jp
View Full Text

Statistics from Altmetric.com

Cited By...

  • 15 Citations
  • Citations
  • Google Scholar

This article has not yet been cited by articles in journals that are participating in Crossref Cited-by Linking.

PreviousNext
Back to top

In this issue

Anticancer Research
Vol. 40, Issue 12
December 2020
  • Table of Contents
  • Table of Contents (PDF)
  • Index by author
  • Back Matter (PDF)
  • Ed Board (PDF)
  • Front Matter (PDF)
Print
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Anticancer Research.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
AMIGO2 Expression as a Potential Prognostic Biomarker for Gastric Cancer
(Your Name) has sent you a message from Anticancer Research
(Your Name) thought you would like to see the Anticancer Research web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
5 + 14 =
Solve this simple math problem and enter the result. E.g. for 1+3, enter 4.
Citation Tools
AMIGO2 Expression as a Potential Prognostic Biomarker for Gastric Cancer
SHUNSUKE NAKAMURA, MITSURO KANDA, DAI SHIMIZU, CHIE TANAKA, YOSHIKUNI INOKAWA, NORIFUMI HATTORI, MASAMICHI HAYASHI, SUGURU YAMADA, GORO NAKAYAMA, KENJI OMAE, MASAHIKO KOIKE, YASUHIRO KODERA
Anticancer Research Dec 2020, 40 (12) 6713-6721; DOI: 10.21873/anticanres.14694

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Reprints and Permissions
Share
AMIGO2 Expression as a Potential Prognostic Biomarker for Gastric Cancer
SHUNSUKE NAKAMURA, MITSURO KANDA, DAI SHIMIZU, CHIE TANAKA, YOSHIKUNI INOKAWA, NORIFUMI HATTORI, MASAMICHI HAYASHI, SUGURU YAMADA, GORO NAKAYAMA, KENJI OMAE, MASAHIKO KOIKE, YASUHIRO KODERA
Anticancer Research Dec 2020, 40 (12) 6713-6721; DOI: 10.21873/anticanres.14694
Twitter logo Facebook logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Abstract
    • Materials and Methods
    • Results
    • Discussion
    • Acknowledgements
    • Footnotes
    • References
  • Figures & Data
  • Info & Metrics
  • PDF

Related Articles

Cited By...

  • Hepatic Stellate Cells Activated by Cancer Cell-derived AMIGO2-containing Small Extracellular Vesicles Promote Cancer Cell Migration by Producing IL-8
  • Clinical Significance of PLA2G2A Expression in Gastric Cancer Patients who Receive Gastrectomy and Adjuvant S-1
  • Google Scholar

More in this TOC Section

  • Musashi1 Enhances Cell Growth and Increases Chemoresistance in Neuroblastoma
  • 6-O-Carboxypropyl-α-Tocotrienol Enhances the Anticancer Effects of Bortezomib Without Suppressing NRF1 and NRF3 in Colorectal Cancer Cells
  • Imbalance Between CD44 and STAT3 Enhances Spheroid Viability and Impairs Pembrolizumab Response in Urothelial Cancer
Show more Experimental Studies

Keywords

  • Gastric cancer
  • AMIGO2
  • prognosis
  • biomarker
Anticancer Research

© 2026 Anticancer Research

Powered by HighWire